Key points are not available for this paper at this time.
The cost-effectiveness of pharmacists and their effect on inpatient health care outcomes were evaluated. For one year, data were collected on all patients receiving care from general medicine and general surgery teams at Walter Reed Army Medical Center, Washington, D. C. Two of five medicine teams and one of three surgery teams included a pharmacist. Teams that included a pharmacist were compared with teams that did not, in terms of patients' length of stay (LOS), mortality, and drug cost per admission. Data were compared for 3081 patients and collected for another 557 who were not included in the comparative study design. Health care teams that included a pharmacist had a shorter log LOS and lower log drug cost per admission but no difference in mortality. The average cost savings for teams that included a pharmacist was 377 per inpatient admission, and the benefit-to-cost ratio was 6. 03: 1. The inclusion of pharmacists on health care teams was cost-effective and provided a favorable benefit-to-cost ratio.
Bjornson et al. (Wed,) studied this question.